Ranking Alexa Global: # 1,432,643
Server:Protected by COMODO ...
The main IP address: 185.17.150.34,Your server United Kingdom,Glasgow ISP:iomart Hosting Limited TLD:uk CountryCode:GB
The description :keywords...
This report updates in 12-Jul-2018
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host acnr.co.uk. Currently, hosted in United Kingdom and its service provider is iomart Hosting Limited .
Latitude: | 55.86515045166 |
Longitude: | -4.2576298713684 |
Country: | United Kingdom (GB) |
City: | Glasgow |
Region: | Scotland |
ISP: | iomart Hosting Limited |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Protected by COMODO WAF mod_bwlimited/1.4 containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 12175 |
Content-Encoding: | gzip |
Expires: | Thu, 12 Jul 2018 04:29:42 GMT |
Vary: | Accept-Encoding |
Keep-Alive: | timeout=5, max=100 |
Server: | Protected by COMODO WAF mod_bwlimited/1.4 |
Connection: | Keep-Alive |
Link: | |
Cache-Control: | private, must-revalidate |
Date: | Thu, 12 Jul 2018 04:19:42 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns33.d9hosting.com. cpanel.d9clients.com. 2018052101 3600 7200 1209600 86400 |
ns: | ns34.d9hosting.com. ns33.d9hosting.com. |
ipv4: | IP:185.17.150.34 ASN:20860 OWNER:IOMART-AS, GB Country:GB |
mx: | MX preference = 10, mail exchanger = mx.spamexperts.com. MX preference = 30, mail exchanger = lastmx.spamexperts.net. MX preference = 20, mail exchanger = fallbackmx.spamexperts.eu. |
-- -- home about issues categories back issues case reports contact latest issue: volume 17, issue 4 – may-july 2018 published on 11th jun 2018 advances in clinical neuroscience & rehabilitation (online) issn 2397-267x fully open access – subscribe here . no fees for authors. read our author guidelines . acnr is a uk-based, international, peer reviewed journal which aims to keep busy practicing specialists up-to-date with the latest advances in their fields, including areas of neurology and neuroscience outside their main area of sub-specialty interest. the major content of acnr is short reviews commissioned independently from leading uk and international experts with a focus on emerging knowledge about clinical neuroscience, neurology, rehabilitation and therapeutics. we will consider submissions of articles, please email the publisher for details. insightec’s focused ultrasound earns positive nice guidance for treatment of essential tremor 2nd jul 2018 posted in industry news news from insightec news from the ean congress 27th jun 2018 posted in courses & conferences conference news from the ean press office nice recommends ocrevus®▼ (ocrelizumab) for people with relapsing-remitting multiple sclerosis 22nd jun 2018 posted in industry news significant milestone for people with multiple sclerosis as people with relapsing-remitting form gain access to new first-in-class treatment with twice-yearly dosing preview: bnos 2018 annual conference 3rd jun 2018 posted in courses & conferences preview: bnos 2018 national neurosciences advisory group neuromuscular event 3rd jun 2018 posted in courses & conferences report on the nnag neuromuscular event taking music therapy into the mainstream 3rd jun 2018 posted in courses & conferences report from chroma conference bnpa 2018 agm report 3rd jun 2018 posted in courses & conferences thomas cope neurovascular disorders: latest treatments and best practice 3rd jun 2018 posted in courses & conferences report from neurovascular disorders meeting managing complex epilepsy – survey 18th may 2018 posted in news review , special feature survey for healthcare professionals - take part and generate a donation to epilepsy charities epistatus®10 mg (in 1 ml) oromucosal solution midazolam available on nhs prescription is approved for use by both the scottish medicines consortium (smc) and the all wales medicines strategy group (awmsg) 2nd may 2018 posted in industry news news from veriton pharma on epistatus page 1 of 65 1 2 3 4 5 ... 10 20 30 ... » last » search watch andrew lees film sign up for our mailing list. first name : last name : email address : popular the msa trust life after encephalitis: ross’s story data provide insight into the mode of action of mavenclad™ (cladribine tablets) in patients with relapsing ms roche’s ocrevus (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis recent articles insightec’s focused ultrasound earns positive nice guidance for treatment of essential tremor news from the ean congress nice recommends ocrevus®▼ (ocrelizumab) for people with relapsing-remitting multiple sclerosis twitter follow @acnrjournal author guidelines advertising sitemap sign up for our mailing list open access, for medical professionals: sign up to receive our email newsletter with links to the latest content. acnr is free, thanks to the support of advertisers. the editorial content is peer reviewed and remains completely independent unless clearly specified. we may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time. see a sample email newsletter here this website is for medical professionals only.
http://www.acnr.co.uk/page/3/
http://www.acnr.co.uk/2018/06/national-neurosciences-advisory-group-neuromuscular-event/
http://www.acnr.co.uk/issue/latest-issue-volume-17-issue-4-may-july-2018/
http://www.acnr.co.uk/2018/06/neurovascular-disorders-latest-treatments-and-best-practice/
http://www.acnr.co.uk/category/courses-conferences/
http://www.acnr.co.uk/2018/06/nice-recommends-ocrevus%e2%96%bc-ocrelizumab-for-people-with-relapsing-remitting-multiple-sclerosis/
http://www.acnr.co.uk/2016/02/the-msa-trust/
http://www.acnr.co.uk/issues/
http://www.acnr.co.uk/about/
http://www.acnr.co.uk/advertising/
http://www.acnr.co.uk/sitemap/
http://www.acnr.co.uk/2018/06/news-from-the-ean-congress/
http://www.acnr.co.uk/2017/07/data-provide-insight-into-the-mode-of-action-of-mavenclad-cladribine-tablets-in-patients-with-relapsing-ms/
http://www.acnr.co.uk/category/special-feature/
http://www.acnr.co.uk/page/65/
ilaebritishconference.org.uk
bnpa.org.uk
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Error for "acnr.co.uk".
the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 908 seconds
WHOIS lookup made at 07:27:19 14-Jul-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS acnr.co.uk
PORT 43
TYPE domain
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
DOMAIN
NAME acnr.co.uk
NSERVER
NS34.D9HOSTING.COM 185.17.150.35
NS33.D9HOSTING.COM 185.17.150.34
The following list shows you to spelling mistakes possible of the internet users for the website searched .